CrossrefInfokarte
Cardiovascular effectiveness of newer glucose-lowering agents, with and without baseline lipid-lowering therapy in type 2 diabetes: A systematic meta-analysis of cardiovascular outcome trials and real-world evidence
Primary Care Diabetes · 2024-12 · 18 (6) · 589-598
DOI: 10.1016/j.pcd.2024.09.007 ↗Abstract
Kein Abstract verfügbar.
EUVIMED